Elena Sani

Laurea in Medicina e Chirurgia e Specializzazione in Endocrinologia e Malattie del Metabolismo presso l’Università degli Studi di Verona.

È membro di società scientifiche in ambito endocrinologico e metabolico, tra cui SID (Società Italiana di Endocrinologia), SIO (Società Italiana dell’Obesità), SISA (Società Italiana per lo Studio dell’Aterosclerosi) e AME (Associazione Medici Endocrinologi), e ha partecipato alla stesura di pubblicazioni scientifiche come autrice e co-autrice.

PRESTAZIONI EFFETTUATE PRESSO LO STUDIO MEDICO PINDEMONTE:

La dott.ssa Sani esegue le seguenti prestazioni:
Visita Endocrinologica
Visita Diabetologica
Visita Matalttie del Metabolismo (dislipidemia, obesità)

PUBBLICAZIONI
Mantovani A, Sani E, Fassio A, Colecchia A, Viapiana O, Gatti D, Idolazzi L, Rossini M, Salvagno G,
Lippi G, Zoppini G, Byrne CD, Bonora E, Targher G. Association between non-alcoholic fatty liver
disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes.
Diabetes Metab. 2019 Sep;45(4):347-355.
Mantovani A, Zusi C, Sani E, Colecchia A, Lippi G, Zaza GL, Valenti L, Byrne CD, Maffeis C, Bonora
E, Targher G. Association between PNPLA3rs738409 polymorphism decreased kidney function in
postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease.
Diabetes Metab. 2019 Oct;45(5):480-487.
Fassio A, Adami G, Idolazzi L, Giollo A, Viapiana O, Bosco E, Negrelli R, Sani E, Sandri D,
Mantovani A, Targher G, Rossini M, Gatti D. Diffuse Idiopathic Skeletal Hyperostosis (DISH) in
Type 2 Diabetes: A New Imaging Possibility and a New Biomarker. Calcif Tissue Int. 2021 Feb;
108(2):231-239.
Olmastroni E, Gazzotti M, Arca M, Averna M, Pirillo A, Catapano AL, Casula M; LIPIGEN Study
Group. Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in
a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or
Without Causative Mutations. J Am Heart Assoc. 2022 Apr 5;11(7):e023668.
Pederiva C, Capra ME, Biasucci G, Banderali G, Fabrizi E, Gazzotti M, Casula M, Catapano AL;
LIPIGEN Paediatric Group; Lipoprotein(a) and family history for cardiovascular disease in
paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN
paediatric group. Atherosclerosis. 2022 May;349:233-239.
Sani E, Prato GD, Zenti MG, Bordugo A, Trombetta M, Bonora E. Effects of Semaglutide on
Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report.
Endocr Metab Immune Disord Drug Targets. 2022 May 9.
Mantovani, A.; Csermely, A.; Sani, E.; Beatrice, G.; Petracca, G.; Lunardi, G.; Bonapace, S.; Lippi, G.;
Targher, G. Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1
Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2
Diabetes. Biomolecules 2022, 12, 943.
Mantovani, A.; Taverna, A.; Cappelli, D.; Beatrice, G.; Csermely, A.; Sani, E.; Byrne, C.D.; Targher,
G. Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients
with Nonalcoholic Fatty Liver Disease: A Pilot Study. Int. J. Mol. Sci. 2022, 23, 12481.
Olmastroni E, Gazzotti M, Averna M, Arca M, Tarugi P, Calandra S, Bertolini S, Catapano AL,
Casula M; LIPIGEN Study Group *. Lipoprotein(a) Genotype Influences the Clinical Diagnosis of
Familial Hypercholesterolemia. J Am Heart Assoc. 2023 May 16;12(10):e029223.
Mantovani A, Csermely A, Castagna A, Antinori E, Danese E, Zusi C, Sani E, Ravaioli F, Colecchia A,
Maffeis C, Valenti L, Girelli D, Targher G. Associations between higher plasma ferritin and
hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory study. Liver
Int. 2023 Jun 14.
Sani E, Da Prato G, Gremes V, Valletta F, Bariani M, Zenti MG. A Case of Wernicke’s
Encephalopathy After Sleeve Gastrectomy. Endocr Metab Immune Disord Drug Targets.
2023;23(12):1548-1551.
Casula M, Gazzotti M, Capra ME, Olmastroni E, Galimberti F, Catapano AL, Pederiva C; LIPIGEN
Group and the LIPIGEN Paediatric Group. Refinement of the diagnostic approach for the
identification of children and adolescents affected by familial hypercholesterolemia: Evidence
from the LIPIGEN study. Atherosclerosis. 2023 Aug 12:117231.
Mantovani A, Csermely A, Cappelli D, Taverna A, Sani E, Shtembari E, Pagani M, Targher G.
Higher circulating levels of non-esterified fatty acids are associated with faster kidney function
decline in post-menopausal women with type 2 diabetes: a pilot prospective study. Acta
Diabetol. 2023 Oct 18.
RETI E AFFILIAZIONI
Ordine dei Medici Chirurghi e Odontoiatri di Verona – VR9289
Società Italiana di Diabetologia – SID
Associazione Medici Endocrinologi – AME
Società Italiana per lo Studio dell’Aterosclerosi – SISA
Società Italiana dell’Obesità – SIO
European Society of Endocrinology – ESE
Society for the Study of Inborn Errors of Metabolism – SSIEM
CONFERENZE E SEMINARI
Nutrizione e Diabete – Corso di formazione SID 2021
27th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism 2021
X Congresso Nazionale SIO 2021
1^ Accademia Diabetologica Triveneto 2021
ESE Clinical Update on Obesity 2021
Corso teorico-pratico patologia tiroidea – Collegium POEMA 2022
SISA LIPID ACADEMY 2022 – Corso avanzato di lipidologia clinica
29° Congresso Nazionale Società Italiana di Diabetologia (SID) 2022
ESE Clinical Update on Calcium and Bone 2022
36° Congresso Nazionale SISA 2022
Congresso interassociativo SID-AMD Veneto Trentino A.A. 2022
ESE Clinical Update on Obesity & Female Reproduction 2023
SCUOLA DI OBESITÀ SIO 2023
SSIEM Inherited Metabolic Diseases Adult Course 2023
ESE Clinical Update on Thyroid Nodules and Carcinomas 2023
CORSO TEORICO PRATICO DI DIAGNOSTICA VASCOLARE- TRONCHI SOVRAORTICI 2023
Incontri pisani di Endocrinologia e Metabolismo – IPEM 2023
XIII Congresso Nazionale SIMMESN (Società Italiana per lo Studio delle Malattie Metaboliche
Ereditarie e lo Screening Neonatale)

PROGETTI
NAFLD e fibrosi epatica in pazienti ambulatoriali con diabete mellito tipo 2: relazione con le
complicanze croniche vascolari e renali – ePoster 28° Congresso Nazionale SID
Liraglutide 3 mg/day in the treatment of obesity – Comunicazione orale, 16th LIPID CLUB AND
THERAPEUTIC APHERESIS MIGHTY MEDIC Org 2021
Sub-investigator dello studio multicentrico OMERO (Studio osservazionale prospettico e
multicentrico sull’efficacia e sulla tollerabilità lungo termine di alirocumab nella reale pratica
clinica in Italia)
Discordant response of LDL-cholesterol and Lipoprotein(a) plasma levels to PCSK9i therapy in a
cohort of hyperLp(a) patients: a single centre experience – ePoster, 35° Congresso Nazionale SISA
2021
Liraglutide for weight management in a real-world setting: experience from a single obesity
center – ePoster, 35° Congresso Nazionale SISA 2021
Effects of Semaglutide on glycemic control and weight loss in a patient with Prader-Willi
syndrome: a case report – ePoster, 24th European Congress of Endocrinology 2022
Efficacy of Lomitapide in adult patients with homozygous familial hypercholesterolemia in a
real-world setting: a case series – Comunicazione orale, Congresso della Sezione Triveneto SISA
2022
Long-term adverse effect of liver stiffness on glycaemic control in type 2 diabetic patients with
non-alcoholic fatty liver disease: a pilot study – Poster, 36° Congresso Nazionale SISA 2022
Real-world use of PCSK9 inhibitors: analysis of data from 180 patients and 5 years of experience
in a single lipid centre – Poster, 36° Congresso Nazionale SISA 2022
Combination of lipoprotein apheresis and alirocumab therapy in a patient with elevated
lipoprotein(a) levels and radiation-induced cardiovascular disease: a case report – Poster, 36°
Congresso Nazionale SISA 2022
Inclisiran, long-acting, synthetic siRNA directed against PCSK9: clinical cases – Comunicazione
orale, 18th LIPID CLUB AND THERAPEUTIC APHERESIS MIGHTY MEDIC Org 2023
A case of Wernicke’s encephalopathy after sleeve gastrectomy- ePoster, 25th European
Congress of Endocrinology 2023
Sub-investigator dello studio multicentrico VICTORION 1 PREVENT (A Study of Inclisiran to
Prevent Cardiovascular Events in High-risk Primary Prevention Patients)
Higher circulating levels of non-esterified fatty acids are associated with faster kidney function
decline in post-menopausal women with type 2 diabetes: a pilot prospective study –
Comunicazione orale, Congresso della Sezione Triveneto SISA 2023
Sub-investigator dello studio multicentrico LOWER (Lomitapide Observational Worldwide
Evaluation Registry)